- India is battling with the burden of hypertension moving to younger age groups
- Hypertension is counted in co-morbidities that make surgeries complicated and even restrict optimized outcomes
- Marengo CIMS Hospital was among the pioneers in India, performing four of the country’s first renal denervation procedures in Ahmedabad using the Simplicity Catheter as early as October 2013
- With the procedure conducted on Thursday, Dr Keyur Parikh has completed one of the highest numbers of RDNs in India
- Research and studies on the global impact of this condition by WHO reveal that at least 4.6 million deaths in India can be averted by 2040 if half of the people with hypertension manage to keep their blood pressure under control.
NE HEALTH BUREAU
AHMEDABAD, MARCH 30
Claiming that people with hard-to-treat, resistant hypertension have an even higher risk of stroke, kidney disease and heart failure, Marengo CIMS Hospital, Ahmedabad has on Friday announced the launch of AI enabled Renal Denervation Therapy (RDT) procedure in Gujarat.
This signifies a remarkable milestone not just for the institution but also for the entire medical fraternity in Gujarat. Marengo CIMS Hospital was among the pioneers in India, performing four of the country’s first renal denervation procedures in Ahmedabad using the Simplicity Catheter as early as October 2013. The hospital stands as the first in Gujarat to embrace the latest breakthrough technology, employing the innovative Simplicity Spyral Renal Denervation System to tackle high blood pressure, a condition of considerable prevalence globally.
The RDT procedure was pioneered at the hospital by Dr Keyur Parikh, Chairman – Marengo CIMS Hospital, Ahmedabad. He is supported by Interventional Cardiologists, Dr Tejas V Patel, and Dr Vipul Kapoor. With the procedure conducted on Thursday, Dr Keyur Parikh has completed one of the highest numbers of RDNs in India. He also treated four such cases 13 years ago with a different technology.
Renal Denervation Therapy presents a revolutionary method for addressing hypertension holding significant potential for patients grappling with severe hypertension. By introducing RDT at Marengo CIMS Hospital, the doctors are positioned to transform the landscape of hypertension management in and around the city boundaries and extend its impact far beyond.
Renal Denervation Therapy (RDN) is a medical procedure used to treat hypertension (high blood pressure) that is resistant to conventional treatments like medication and lifestyle changes. The procedure involves using either radiofrequency energy or ultrasound to decrease nerves in the renal arteries, which are the arteries that supply blood to the kidneys. These nerves play a role in regulating blood pressure by sending signals to the brain. The theory of the RDT is that by disrupting the signals from these nerves, blood pressure can be lowered. The procedure is typically performed using a catheter that is inserted through a small incision in the groin and threaded up to the renal arteries. Once installed the energy source is used to destroy the nerves surrounding the arteries selectively.
Dr Keyur Parikh, Chairman – Marengo CIMS Hospital said, “We have endeavored to highlight the significance of the RDN in addressing hypertension management to commemorate this achievement and share insights into the potential impact of Renal Denervation Therapy. We have showcased the innovative techniques and expertise involved in the procedure, underscoring Marengo CIMS Hospital’s commitment to medical excellence. We have, at the same time, enumerated the anticipated long-term benefits and outcomes for patients undergoing Renal Denervation Therapy with the intent of creating increased awareness about this therapy. The potential of RDT in improving patient outcomes will augment collaborations and dialogue within the medical community to advance renal care and innovation further.”
Speaking with navjeevanexpress.com, Dr Parikh said, “The cost of catheter is Rs 5 lakh to Rs 6 lakh and the treatment cost comes around Rs 2 lakh, but it is not covered under the PMJAY. The safety of this procedure on a 60-year-old woman, and as demonstrated in the trial, is exciting as it opens up a new avenue of treatment for appropriately selected patients with hypertension. However, the patient will get the required relief only after 3 or 4 months.”
Dr Raajiv Singhal, Managing Director & Group CEO, Marengo Asia Hospitals says, “As our team of doctors embark on this ground-breaking journey of introducing the RDN, we further augment our commitment to innovation and advancing patient care.”
Dr Tejas V Patel, Interventional Cardiologist says, “India alone is home to 220 million adults globally and this is a cause for huge concern. It is also a high co-morbidity that prevents optimized outcomes to treatment solutions applied to many patients. Above all, high blood pressure impacts the heart significantly and can also lead to a fast deterioration of the functioning of the organ. With RDN, we attempt to arrest factors that can lead to serious conditions. This does not cause any side effect.”
Dr Vipul Kapoor, Interventional Cardiologist says, “Renal Denervation Therapy (RDN) heralds a new era in the management of hypertension and its associated cardiovascular risks. By selectively targeting the sympathetic nerves in the renal arteries, RDT offers a minimally invasive yet highly effective means of blood pressure control, particularly in patients resistant to conventional treatments holding a promise in mitigating the progression of heart disease and improving patient outcomes. This procedure will help the patient to reduce the number of tablets from 4 to 6 per day to 1 to 3. However, medication has to be continued. ”
High blood pressure is one of the world’s highest risk factors for death and disability. Even after being diagnosed, people refrain from taking medications. The number of hypertensive patients in India is expected to double from 118.2 million in 2000 to 213.5 million by 2025, establishing India as the ‘hypertension capital of the world’. Research and studies on the global impact of this condition by WHO reveal that at least 4.6 million deaths in India can be averted by 2040 if half of the people with hypertension manage to keep their blood pressure under control.
